To examine whether antecedent antimicrobial use influenced subsequent relative risk of urinary tract infection (UTI) in premenopausal women, data were analyzed from two cohorts of women observed prospectively for 6 months to determine risk factors for UTI. Using a Cox proportional hazards model to adjust for covariates, we found that 326 women in a University cohort and 425 women in a health-maintenance organization cohort were at increased risks for UTI (2. than one UTI during the prior year, were not pregnant or planIn addition, experimental animal studies have shown that ning to become pregnant, had not used systemic antimicrobials exposure to certain antimicrobials alters the normal vaginal during the past 14 days, had no chronic illness requiring mediflora and facilitates subsequent vaginal colonization with urocal supervision, and had no known anatomic or functional abpathogens [7, 8] . It is not known, however, whether antecedent normality of the urinary tract. All patients gave written inantimicrobial use predisposes women to UTI. To address this formed consent, and the study was approved by the University issue, we analyzed data from two cohorts of premenopausal of Washington and Group Health Cooperative Human Subjects women who were followed longitudinally in a prospective Review Committees. study of risk factors for UTI. Since the women recorded antimiSubjects in the University cohort were seen at enrollment crobial use in a daily diary, it was possible to examine the and then at weekly intervals for the first month and monthly effect of antimicrobial use on risk of subsequent UTI. intervals for the remaining 5 months. At the HMO, subjects were seen at enrollment and every 2 months. At both sites, all subjects were requested to record in daily diaries information Methods on sexual intercourse, contraceptive use, menstruation, anti-
Uncomplicated urinary tract infections (UTIs) in women acsisted of two cohorts of young, sexually active women studied count for ú7 million office visits in the United States each between 1989 and 1993. The first cohort was a sample of year [1] . Factors associated with an increased risk of UTI in women who sought health care at the University of Washington women include sexual intercourse, diaphragm-spermicide use, Student Health Center. The second cohort consisted of women nonsecretor status, and a history of recurrent UTI [2 -5] . Vagienrolled in Group Health Cooperative of Puget Sound, a staffnal colonization with Escherichia coli generally precedes UTI, model health maintenance organization (HMO) in Seattle. and alterations in the normal vaginal flora, favoring colonizaEligible women were between 18 and 40 years of age, were tion with uropathogens, are thought to explain why diaphragmstarting a new birth control method, had experienced no more spermicide use is associated with an increased risk of UTI [6] .
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Study Design
microbial use (yes/no), presence of vaginal and urinary symptoms, and postcoital voiding. The type of antimicrobial used The study design and data-collection instruments have been was determined retrospectively via self-report at the follow-up previously described [2] . In brief, the study population convisits. Subjects were followed for 6 months at both sites. In addition to the scheduled follow-up visits, University subjects were in-
Measures of Antimicrobial Use
period. Information on UTI events was then collected during the next follow-up visit.
In all of the analyses, missing data were handled in a consistent fashion. Women without diary data during the prior 7-day period were excluded from the analysis because the required Definition of UTI covariate information for the base model (e.g., intercourse, Subjects were considered to have a culture-confirmed UTI if diaphragm-spermicide use) was missing. For analyses involvthey had dysuria, frequency, and/or urgency and §10 2 cfu of a ing longer periods, women who did not have diary information uropathogen per milliliter of midstream urine [9] . Subjects were during the entire period of interest were not automatically exconsidered to have a probable UTI if they had dysuria, frecluded. If a woman recorded antimicrobial use on any day quency, and/or urgency as well as either written diagnosis of a during the period of interest, she was considered an antimicro-UTI by their provider (if no urine culture was performed) or bial user -even if she was not followed for the entire period. documentation of treatment with a urinary antimicrobial. For However, if she was not followed for the entire period and did our analyses, a woman was considered to have a UTI if she met not record any antimicrobial use during the portion of the the criteria for either a culture-confirmed or probable UTI. period for which she had diary data, the antimicrobial variable was considered missing and that period was excluded from the analysis since there was no way to determine whether or not
Statistical Methods
an antimicrobial had been taken during the missing portion of the period. UTI incidence rates were defined as the total number of Analyses were performed for any antimicrobial use during UTIs during follow-up divided by the total number of personthe previous 3 days, the previous 7 days, the previous 14 days, years at risk (i.e., the sum of the total number of years each and the previous 15 -28 days (regardless of antimicrobial use woman was at risk for a UTI during follow-up). The Cox during the previous 14 days). Antimicrobials were divided into proportional hazards model [10] was used to determine the three groups: b-lactam drugs (amoxicillin, ampicillin, amoxirelative contribution of various factors to the risk of UTI. The cillin/clavulanate, cefotetan, cephalexin, cephradine, dicloxacounting-process formulation of the Cox model [11] was used cillin, penicillin, and cefaclor); trimethoprim and TMP-SMZ; to model multiple UTIs per woman, and the robust variance and all remaining agents (doxycycline, erythromycin, tetracycorrection of Lin [12] was used to control for possible intrasubcline, azithromycin, nitrofurantoin, ciprofloxacin, norfloxacin, ject correlation. Time zero for the Cox model was taken to be and gentamicin). the beginning of the study, and real calendar time was used as Analyses using these measures suggested that antimicrobial the time scale for all analyses. Therefore, any seasonal effects use during the prior 15 -28-day period may be a risk factor for (which are not included as part of the model) were absorbed UTI (see Results). Since more recent antimicrobial use may into the baseline hazard. With this approach, the covariates be expected to provide protection from UTI, we defined a ''risk (e.g., antibiotic use) of each woman at the time she experienced period'' as the prior 15 -28 days and a ''protective period'' as a UTI were compared to those of all other women without UTI the prior 7 days. We evaluated whether antimicrobial use durwho were being followed at that time. A woman was removed ing the risk period, stratified by use during the protective period, from the risk set in the Cox model for 5 days following a UTI.
increased risk of UTI. Hooton et al. described site-specific models for UTI in the Antimicrobial use during the previous 8 -14-day period was University and HMO cohorts, using a common set of covariates ignored in this analysis because it was found to neither increase [2] . These included intercourse frequency, frequency of dianor decrease risk for UTI (data not shown). To determine phragm-spermicide use, frequency of cervical cap use, spermiwhether antecedent antimicrobial use was simply a surrogate cide use (yes/no), history of UTI prior to study entry ( §2 for previous UTI (which is a known risk factor for subsequent UTIs), age, and marital status (married/not married). This set UTI [2] ), analyses were performed according to whether antiof covariates is denoted as the ''base model'' in our analyses microbial use in the previous 15 -28 days was for the treatment of antimicrobial use. We examined the effect of antimicrobial of a UTI or for other reasons. use on UTI risk after controlling for the factors in the base model.
The analyses of antimicrobial use presented here explored Results the effect of several different periods of antimicrobial use on risk of UTI. In any exploratory data analysis of this nature, the The University clinic enrolled 363 women and the HMO enrolled 456 women. Thirteen women in the University cohort potential exists for spurious positive findings due to multiple testing. We have chosen to report unadjusted P values because never returned for follow-up, two never started their study birth-control method, and 22 did not record any diary informaour interest lies in the individual hypotheses tested. However, the qualitative conclusions reported here are unchanged if adtion. These women were excluded from further analysis. Eight women were excluded from the HMO cohort for lack of followjustments for multiple testing are performed.
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06-10-97 08:49:45 cida UC: CID came self-colonized with E. coli [13] . After cessation of antimicrobial therapy, E. coli colonization persisted throughout the 29 days of follow-up, and the indigenous flora only slowly week as well as during the previous 15 -28 days, in comparison with the risk for women who did not use an antimicrobial returned to normal. In contrast, administration of two non-b-lactam drugs, triduring these periods (table 3) .
An increased risk of UTI was seen for each category of methoprim and nitrofurantoin, in monkey vaginas did not cause E. coli colonization [14]; these drugs have also been shown to antimicrobial that could be evaluated, although the confidence intervals were quite wide. There did not appear to be a differenaffect normal flora less than the b-lactam ampicillin in in vitro studies of cells from girls [15] . Taken together, these studies tial effect on risk of UTI in a comparison of b-lactam drugs vs. trimethoprim or TMP-SMZ, although the small amount of lend strong support to the hypothesis that an antimicrobial that alters indigenous vaginal flora may increase susceptibility to data in these subcategories makes it difficult to address this issue with any confidence. The effect of b-lactam drugs could vaginal colonization and thus to UTI with E. coli.
Regarding the influence of antimicrobials on vaginal coloninot be assessed at the University because no UTIs occurred in this group. zation with uropathogens in humans, Reid et al. found that 4 -6 weeks following antimicrobial treatment with the b-lactam To determine if the effect of antimicrobial use in the previous 15 -28 days on risk of UTI was because the antimicrobials drugs amoxicillin and bacampicillin for cystitis, the predominant urogenital bacteria in the majority of women studied were were used to treat a previous UTI (a known risk factor for subsequent UTI), antimicrobial use during the prior 15 -28 uropathogens, which had replaced the indigenous lactobacilli population [16] . On the other hand, Hooton et al. found that days was separated into UTI treatment vs. treatment for another type of infection. While there were relatively few recurrent ofloxacin and TMP-SMZ caused less vaginal colonization with E. coli following treatment for cystitis than did amoxicillin UTIs in this study (only 7% of the women at the University and 3% at the HMO had ú1 UTI), a suggestion of a differential or cephadroxil [17, 18] . Women treated with ofloxacin or TMP-SMZ had the highest UTI cure rates at 6 weeks posteffect was seen ( [6] .
In the data we report here, we found that antimicrobials used of concurrent use at the University and nine person-days at the HMO. for treatment of a UTI were associated with a higher risk of subsequent UTI than were antimicrobials used for other ill-
The increase in UTI risk associated with antimicrobial use was consistently greater at the HMO than at the University. nesses. This effect was clearly evident in the HMO cohort but less strikingly present in the University cohort. The magnitude
The explanation for this difference is not readily apparent. The two samples represent substantially different populations in of the increased risk (RR Å 2.9 in the University cohort and 6.4 in the HMO cohort) is comparable to the increase in risk terms of age, history of UTI, marital status, and choice of birth control method. It is possible that selected risk factors may associated with about 5 days of diaphragm-spermicide use in the previous week or with history of UTI prior to study enrollplay a relatively greater role in each population; thus, perhaps frequency of sexual intercourse and spermicide exposure are ment [2] .
In women given antimicrobials for UTI, the UTI risk associthe predominant factors among the younger, unmarried University women, while antimicrobial exposure is more important ated with previous antimicrobial use may simply reflect the effect of other risk factors for UTI that are still present in the among the HMO women. Although we attempted to control for each of these factors patients. While the model we used adjusted for other known risk factors such as frequency of sexual intercourse and diain our multivariate analysis, there could be unmeasured behavioral differences or other undiscovered exposures that differ phragm-spermicide use, there may be other unrecognized risk factors that predisposed patients to both first and recurrent between the two cohorts. Alternatively, the differential effects observed could be the result of different antimicrobial-prescribepisodes of UTI. Kunin et al. have postulated that one UTI increases the risk for a subsequent UTI [19] , and we and others ing behaviors among physicians at the two sites. In summary, antimicrobial use during the previous 15 -28 have shown that history of a UTI is a strong risk factor for subsequent UTI [2, 4, 5] . Thus, antimicrobial use may be only days (without use during the previous week) was associated with an increased risk of uncomplicated cystitis in young a risk marker for UTI.
However, in the HMO cohort, the risk associated with prior women. The strengths of our study included the large number of women at risk for UTI who were followed prospectively antimicrobial use remained elevated even if the indication was for treatment of something other than a UTI, a finding sugfor 6 months each; daily recordings of antimicrobial use by these women; detailed assessment of other risk factors for UTI; gesting that prior UTI does not fully explain the increase in risk associated with antimicrobial use. These data are consistent and comparison of analyses in two different populations of women at risk for UTI. with the concept that the increased risk of UTI due to previous antimicrobial use results from alteration of the indigenous vagiDespite these strengths, the use of many different types and durations of antimicrobial treatment made it difficult to assess nal flora and facilitation of colonization with uropathogens.
Our analysis showed that if antimicrobials were also used the effect of specific antimicrobials in this dataset. Furthermore, as in any nonrandomized, observational study, our ability to in the previous week, there was no increased risk of subsequent UTI, a finding suggesting that such patients may in essence be make causal inferences is limited, and the potential for biases exists. Thus, additional research is needed to confirm our reprotected from infection by low levels of antimicrobial in the urine (i.e., antimicrobial prophylaxis). We were not able to sults. Such studies should address the differential effects of specific types of antimicrobial use on risk of subsequent UTI, adjust for the type of antimicrobial or duration of use of the antimicrobial because of the limited amount of antimicrobial in particular comparing b-lactam drugs such as amoxicillin or cephalosporins with trimethoprim, TMP-SMZ, and fluoroquiuse in both cohorts.
On the basis of previous studies, we hypothesized that nolones. Use of antimicrobials for indications other than UTI should b-lactam drugs, which markedly alter the normal vaginal and fecal flora [16, 20] , would lead to an increased susceptibility be compared with use of antimicrobials for treatment of UTI. If specific types of antimicrobials can be identified as important to UTI, whereas drugs that have less effect on the indigenous (mainly anaerobic) flora (e.g., TMP-SMZ) might provide a risk factors for UTI, it is likely that preventive strategies can be developed to reduce the risk of UTI in women taking antiprotective effect against UTI [14] . However, our results showed that in the HMO cohort, trimethoprim and TMP-SMZ as well microbials. as b-lactam drugs were associated with increased risk of UTI if the antimicrobial was taken within the previous 15 -28 days.
